Status:
UNKNOWN
ECT Schizophrenia Serotonin Study
Lead Sponsor:
Sha'ar Menashe Mental Health Center
Conditions:
Schizophrenia
Eligibility:
All Genders
18-55 years
Brief Summary
We suggest to investigate serotonin uptake in schizophrenia patients receiving ECT
Detailed Description
We suggest to investigate serotonin uptake in schizophrenia patients receiving ECT
Eligibility Criteria
Inclusion
- Participants must meet DSM-IV criteria for schizophrenia, as assessed by the Structured Clinical Interview - Patient Version (SCID) (First et al., 1995).
- Ages 18 -55 Men and/or women -
Exclusion
- History of neurological disorders, active substance abuse in the previous 3 months.
- Estimated IQ less then 70.
- SSRIs treatment 4 weeks prior to the study.
- Any subject suffering from inflammatory fever disease will be excluded from the study.
- \-
Key Trial Info
Start Date :
October 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2006
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00278668
Start Date
October 1 2006
End Date
October 1 2006
Last Update
May 21 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.